Emmaus Life Sciences EMMA
OTC EMMA
$0.06 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Emmaus Life Sciences (EMMA) Return on Equity [ROE] (2017 - 2018)

Updated

Emmaus Life Sciences (EMMA) reported Return on Equity [ROE] of -87.82% for Q2 2018, up 2289.41 percentage points from -2377.23% a year earlier but down 13.88 percentage points from the prior quarter.

Analysis

Emmaus Life Sciences (EMMA) Return on Equity [ROE] (2017 - 2018) Analysis & Trends

For FY2017, Emmaus Life Sciences posted Return on Equity [ROE] of -408.44%.

  • Five-year quarterly Return on Equity [ROE] spans a low of -2377.23% in Q2 2017 and a high of -73.94% in Q1 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 19.33%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.21%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 31.52%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 21.39%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 83.75%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -18.38%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 4.97%
10 Emmaus Life Sciences 4.21 Mn -2.09 Mn 5.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 -87.82%
Dec 31, 2017 -73.94%
Sep 30, 2017 -395.78%
Mar 31, 2017 -2,377.23%
API Access

Emmaus Life Sciences Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EMMA&period=max&api_key=YOUR_API_KEY